Literature DB >> 1863127

Doppler assessment of pulmonary artery pressure during recovery from hyaline membrane disease.

N J Evans1, L N Archer.   

Abstract

The changes in pulmonary artery pressure during recovery from hyaline membrane disease were studied by serial Doppler echocardiography on 37 preterm infants. Pulmonary artery pressure was assessed noninvasively by its inverse relationship with the ratio of pulmonary artery Doppler time to peak velocity and right ventricular ejection time. The pattern of rise in ratio after the acute phase of hyaline membrane disease divided into three types. In 25 infants the ratio returned to the normal range: in 12 (group 1) at the same time as the fractional inspired oxygen fell below 0.5 and in 13 (group 2) after a delay of at least 24 hours. In 12 infants (group 3) the ratio remained below the normal range during their hospital stay, suggesting pulmonary artery pressure remained high. Infants in group 3 were of significantly lower gestation and required oxygen treatment for significantly longer than infants in groups 1 and 2. Persistently raised pulmonary pressures in group 3 may reflect lung damage either directly affecting pulmonary vasculature or exerting a secondary effect on pulmonary vascular resistance through hypoxaemia.

Entities:  

Mesh:

Year:  1991        PMID: 1863127      PMCID: PMC1590228          DOI: 10.1136/adc.66.7_spec_no.802

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

1.  Lung function in children of low birth weight.

Authors:  K N Chan; C M Noble-Jamieson; A Elliman; E M Bryan; M Silverman
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

2.  Postnatal circulatory adaptation in healthy term and preterm neonates.

Authors:  N J Evans; L N Archer
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

3.  Pulmonary hypertension in infants with bronchopulmonary dysplasia.

Authors:  G Goodman; R M Perkin; N G Anas; D R Sperling; D A Hicks; M Rowen
Journal:  J Pediatr       Date:  1988-01       Impact factor: 4.406

4.  Bronchopulmonary dysplasia: a morphometric study with emphasis on the pulmonary vasculature.

Authors:  J F Tomashefski; H C Oppermann; G F Vawter; L M Reid
Journal:  Pediatr Pathol       Date:  1984

5.  Pulse oximeter and transcutaneous arterial oxygen measurements in neonatal and paediatric intensive care.

Authors:  D P Southall; S Bignall; V A Stebbens; J R Alexander; R P Rivers; T Lissauer
Journal:  Arch Dis Child       Date:  1987-09       Impact factor: 3.791

6.  Factors affecting use of the Doppler-determined time from flow onset to maximal pulmonary artery velocity for measurement of pulmonary artery pressure in children.

Authors:  G A Serwer; A G Cougle; J M Eckerd; B E Armstrong
Journal:  Am J Cardiol       Date:  1986-08-01       Impact factor: 2.778

7.  Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique.

Authors:  A Kitabatake; M Inoue; M Asao; T Masuyama; J Tanouchi; T Morita; M Mishima; M Uematsu; T Shimazu; M Hori; H Abe
Journal:  Circulation       Date:  1983-08       Impact factor: 29.690

8.  Doppler assessment of pulmonary artery pressure and extrapulmonary shunting in the acute phase of hyaline membrane disease.

Authors:  N J Evans; L N Archer
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

  8 in total
  12 in total

1.  Changes in pulmonary arterial pressure in preterm infants with chronic lung disease.

Authors:  N V Subhedar; N J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

2.  Can fetal pulmonary artery Doppler indices predict neonatal respiratory distress syndrome?

Authors:  G A F A Moety; H M Gaafar; N M El Rifai
Journal:  J Perinatol       Date:  2015-10-22       Impact factor: 2.521

3.  Doppler assessment of pulmonary artery pressure in neonates at risk of chronic lung disease.

Authors:  B H Su; T Watanabe; M Shimizu; M Yanagisawa
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-07       Impact factor: 5.747

4.  Changes in pulmonary artery pressure in infants with respiratory distress syndrome following treatment with Exosurf.

Authors:  A H Hamdan; N J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-05       Impact factor: 5.747

5.  Raised pulmonary artery pressure in very low birthweight infants requiring supplemental oxygen at 36 weeks after conception.

Authors:  A B Gill; A M Weindling
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-01       Impact factor: 5.747

6.  Randomised controlled trial of postnatal sodium supplementation in infants of 25-30 weeks gestational age: effects on cardiopulmonary adaptation.

Authors:  G Hartnoll; P Bétrémieux; N Modi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-07       Impact factor: 5.747

7.  Echocardiographic Assessment of Right Ventricular Afterload in Preterm Infants: Maturational Patterns of Pulmonary Artery Acceleration Time Over the First Year of Age and Implications for Pulmonary Hypertension.

Authors:  Meghna D Patel; Colm R Breatnach; Adam T James; Swati Choudhry; Patrick J McNamara; Amish Jain; Orla Franklin; Aaron Hamvas; Luc Mertens; Gautam K Singh; Afif El-Khuffash; Philip T Levy
Journal:  J Am Soc Echocardiogr       Date:  2019-07       Impact factor: 5.251

8.  Pulmonary artery pressure changes in the very low birthweight infant developing chronic lung disease.

Authors:  A B Gill; A M Weindling
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

9.  Subclinical persisting pulmonary hypertension in chronic neonatal lung disease.

Authors:  D Fitzgerald; N Evans; P Van Asperen; D Henderson-Smart
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-03       Impact factor: 5.747

Review 10.  Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia.

Authors:  Christopher D Baker; Steven H Abman; Peter M Mourani
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-03-01       Impact factor: 1.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.